Ambulatory high-dose 5-day continuous-infusion ifosfamide combination chemotherapy in advanced solid tumors: a feasibility study

Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.

Anthony Elias, Louise Ryan, Aarón Sulkes et al. · Journal of Clinical Oncology · 1989 · 281 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomas

Vivien Bramwell, Henning T. Mouridsen, Armando Santoro et al. · European Journal of Cancer and Clinical Oncology · 1987 · 243 citations

Medicine, Oncology, Pharmacology +8

Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.

K H Antman, Louise Ryan, Alby Elias et al. · Journal of Clinical Oncology · 1989 · 239 citations

Medicine, Oncology, Pharmacotherapy +15

High-dose ifosfamide with mesna uroprotection: a phase I study.

Anthony Elias, Joseph P. Eder, Colin B. Begg et al. · Journal of Clinical Oncology · 1990 · 145 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Comparative study on human pharmacokinetics of activated ifosfamide and cyclophosphamide by a modified fluorometric test

T. Wagner, D. Heydrich, T. Jork et al. · Journal of Cancer Research and Clinical Oncology · 1981 · 72 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +10